(Q42140893)

English

Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy

scientific article published on 13 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy (English)

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Michael J. Morris

3

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Steven M. Larson

8

object named as

Steven M Larson

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

7

object named as

Howard I Scher

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

author name string

Neeta Pandit-Taskar

1

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Joseph A O'Donoghue

2

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Eze A Wills

4

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Lawrence H Schwartz

5

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Mithat Gonen

6

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Chaitanya R Divgi

9

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

language of work or name

0 references

publication date

13 June 2008

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

The Journal of Nuclear Medicine

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

49

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

7

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

1066-1074

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

29 May 2018

Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

29 May 2018

Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

29 May 2018

Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

29 May 2018

Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

29 May 2018

Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

29 May 2018

Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

29 May 2018

Bone marrow dosimetry for radioimmunotherapy: theoretical considerations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

29 May 2018

Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

17 August 2018

Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

17 August 2018

SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766795

17 August 2018

Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18552139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18552139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium

1 reference

https://pubmed.ncbi.nlm.nih.gov/18552139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18552139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indium-111 capromab pendetide (ProstaScint) imaging to detect recurrent and metastatic prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18552139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific membrane antigen expression in normal and malignant human tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/18552139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18552139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18552139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18552139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18552139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2967/JNUMED.107.049502

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42140893&oldid=2185984105"